BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14626298)

  • 21. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
    Daldrup-Link HE; Shames DM; Wendland M; Mühler A; Gossmann A; Rosenau W; Brasch RC
    Acad Radiol; 2000 Nov; 7(11):934-44. PubMed ID: 11089696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI.
    Wang S; Delproposto Z; Wang H; Ding X; Ji C; Wang B; Xu M
    PLoS One; 2013; 8(7):e67731. PubMed ID: 23844077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast disease: dynamic spiral MR imaging.
    Daniel BL; Yen YF; Glover GH; Ikeda DM; Birdwell RL; Sawyer-Glover AM; Black JW; Plevritis SK; Jeffrey SS; Herfkens RJ
    Radiology; 1998 Nov; 209(2):499-509. PubMed ID: 9807580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging.
    Kvistad KA; Lundgren S; Fjøsne HE; Smenes E; Smethurst HB; Haraldseth O
    Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
    Turkat TJ; Klein BD; Polan RL; Richman RH
    J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
    Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
    Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters.
    Szabó BK; Aspelin P; Wiberg MK
    Acad Radiol; 2004 Dec; 11(12):1344-54. PubMed ID: 15596372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose)--first clinical experiences.
    Sandstede JJ; Pabst T; Wacker C; Wiesmann F; Hoffmann V; Beer M; Kenn W; Bauer W; Hahn D
    Magn Reson Imaging; 2001 Feb; 19(2):201-5. PubMed ID: 11358658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential diagnosis of intra- and perilienal tumors by use of a RES-specific MRI contrast agent].
    Gaffke G; Stroszczynski C; Gnauck M; Jost D; Chmelik P; Ludwig WD; Gretschel S; Felix R
    Rontgenpraxis; 2004; 55(5):192-9. PubMed ID: 15700656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
    Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
    Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI.
    Gilles R; Meunier M; Lucidarme O; Zafrani B; Guinebretière JM; Tardivon AA; Le Gal M; Vanel D; Neuenschwander S; Arriagada R
    J Comput Assist Tomogr; 1996; 20(1):9-14. PubMed ID: 8576489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.